| Stock | Role | Class | Num Shares | Value | Price $ | Report Date | Ownership |
|---|---|---|---|---|---|---|---|
| Elevation Oncology, Inc. | CHIEF SCIENTIFIC OFFICER | Restricted Stock Unit | 37.5K | $19.1K | $0.51 | 15 Feb 2024 | Direct |
| Elevation Oncology, Inc. | CHIEF SCIENTIFIC OFFICER | Restricted Stock Unit | 28.1K | $18.9K | $0.67 | 15 Feb 2025 | Direct |
| Elevation Oncology, Inc. | CHIEF SCIENTIFIC OFFICER | Common Stock | 5.22K | $3.51K | $0.67 | 15 Feb 2025 | Direct |
| Aadi Bioscience, Inc. | Chief Scientific Officer | Stock Option (right to buy) | 688K | 04 Mar 2025 | Direct | ||
| Elevation Oncology, Inc. | CHIEF SCIENTIFIC OFFICER | Stock Option (Right to Buy) | 225K | 15 Feb 2024 | Direct | ||
| Bolt Biotherapeutics, Inc. | Chief Scientific Officer | Stock Option (Right to Buy) | 210K | 18 Feb 2022 | Direct |
| Symbol | Company | Period | Transactions | Value $ | Form Type | Role | Filing Time |
|---|---|---|---|---|---|---|---|
| AADI | Aadi Bioscience, Inc. | 04 Mar 2025 | 1 | $0 | 4 | Chief Scientific Officer | 04 Mar 2025, 18:11 |
| AADI | Aadi Bioscience, Inc. | 18 Feb 2025 | 0 | $0 | 3 | Chief Scientific Officer | 18 Feb 2025, 16:58 |
| ELEV | Elevation Oncology, Inc. | 15 Feb 2025 | 3 | -$2.79K | 4 | CHIEF SCIENTIFIC OFFICER | 19 Feb 2025, 16:15 |
| ELEV | Elevation Oncology, Inc. | 15 Feb 2024 | 2 | $0 | 4 | CHIEF SCIENTIFIC OFFICER | 20 Feb 2024, 16:52 |
| ELEV | Elevation Oncology, Inc. | 15 Feb 2023 | 1 | $0 | 4 | CHIEF SCIENTIFIC OFFICER | 17 Feb 2023, 15:26 |
| ELEV | Elevation Oncology, Inc. | 06 Jan 2023 | 1 | $0 | 4 | CHIEF SCIENTIFIC OFFICER | 10 Jan 2023, 15:27 |
| ELEV | Elevation Oncology, Inc. | 14 Mar 2022 | 1 | $0 | 4 | Chief Scientific Officer | 16 Mar 2022, 17:46 |
| ELEV | Elevation Oncology, Inc. | 14 Mar 2022 | 0 | $0 | 3 | Chief Scientific Officer | 16 Mar 2022, 17:42 |
| BOLT | Bolt Biotherapeutics, Inc. | 18 Feb 2022 | 1 | $0 | 4 | Chief Scientific Officer | 23 Feb 2022, 20:19 |